1. Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 2005;162:1452–60. [PMC free article] [PubMed] 2. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58:55–66. [PubMed] 3. Stanton MD, Shadish WR. Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol Bull. 1997;122:170–91. [PubMed] 4. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843–61. [PubMed] 5. Irvin JE, Bowers CA, Dunn ME, Wong MC. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol. 1999;67:563–70. [PubMed]
6. Nathan PE, Gorman JM. A Guide to Treatments That Work. 2. New York: Oxford University Press; 2002.
7. Chambless DL, Ollendick TH. Empirically supported psychological interventions: controversies evidence. Annu Rev Psychol. 2001;52:685–716. [PubMed]
8. Roth A, Fonagy P. What Works for Whom? a Critical Review of the Psychotherapy Literature. 2. New York: Guilford Press; 2005.
9. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine. New York: Churchill Livingstone; 1997.
10. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998;66:7–18. [PubMed] 11. Beutler LE. David and Goliath: when empirical and clinical standards of practice meet. Am Psychol. 2000;55:997–1007. [PubMed] 12. Sanderson WC. Why empirically supported psychological treatments are important. Behav Modif. 2003;27:290–9. [PubMed] 13. Follette WC, Beitz K. Adding a more rigorous scientific agenda to the empirically supported treatment movement. Behav Modif. 2003;27:369–86. [PubMed] 14. Rosen GM, Davidson GC. Psychology should list empirically suported principles of change (ESPs) and not credential trademarked therapies or other treatment packages. Behav Modif. 2003;27:300–12. [PubMed] 15. Westen D, Novotney CM, Thompson-Brenner H. The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychol Bull. 2004;130:631–63. [PubMed]
16. Garfield SL. Some problems associated with ‘validated’ forms of therapy. Clin Psychol Sci Pract. 1996;3:218–29.
17. Wampold BE, Bhati KS. Attending to the omissions: a historical examination of evidence-based practice movements. Profess Psychol Res Pract. 2004;35:563–70.
18. Herbert JD. The science and practice of empirically supported treatments. Behav Modif. 2003;27:412–30. [PubMed]
19. Institute of Medicine. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press; 1998.
20. Institute of Medicine. Crossing the Quality Chasm: a New Mental Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
21. Fals-Stewart W, Logsdon T, Birchler GR. Diffusion of an empirically supported treatment for substance abuse: an organizational autopsy of technology transfer success and failure. Clin Psychol Sci Pract. 2004;11:177–82.
22. McLellan AT, McKay JR. The treatment of addiction: what can research offer practice? In: Lamb S, Greenlick MR, McCarty D, editors. Bridging the gap between practice and research: forging partnerships with community based drug and alcohol treatment. Washington, DC: National Academy Press; 1998. pp. 147–85.
23. Margolin A, Kleber HD, Avants SK, et al. Acupuncture for the treatment of cocaine addiction: a randomized controlled trial. JAMA. 2002;287:55–63. [PubMed] 24. Dishion TJ, McCord J, Poulin F. When interventions harm: peer groups and problem behavior. Am Psychol. 1999;54:755–64. [PubMed] 25. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003;2:CD002209. [PubMed] 26. Masson CL, Barnett PG, Sees KL, Delucchi KL, Rosen A, Wong W, et al. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. 2004;99:718–26. [PubMed] 27. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat. 2003;25:117–21. [PubMed] 28. Babor TF, Higgins-Biddle JC. Alcohol screening and brief intervention: dissemination strategies for medical practice and public health. Addiction. 2000;95:677–86. [PubMed]
29. Lambert ME, Whipple JL, Vermeersch DA, Nielsen SL, Smart DW. Is it time for clinicians to routinely track patient outcome? A meta-analysis. Clin Psychol Sci Pract. 2003;10:288–301.
30. Luborsky L, Rosenthal R, Diguer L, Andrusyna TP, Berman JS, Levitt JT, et al. The dodo bird verdict is alive and well—mostly. Clin Psychol Sci Pract. 2002;9:2–12.
31. Luborsky L, Singer B, Luborsky L. Comparative studies of psychotherapies: is it true that ‘Everyone has won all must have prizes’? Arch Gen Psychiatry. 1975;32:995–1008. [PubMed] 32. Project MATCH Research Group. Matching alcohol treatments to client heterogeneity: Project MATCH posttreatment drinking. J Stud Alcohol. 1997;58:7–29. [PubMed] 33. UK Alcohol Treatment Trial (UKATT) Research Team. Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT) BMJ. 2005;331:541. [PMC free article] [PubMed] 34. Morgenstern J, Blanchard KA, Morgan TJ, Labouvie E, Hayaki J. Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings. J Consult Clin Psychol. 2001;69:1007–17. [PubMed]
35. Addis ME, Waltz J. Implicit and untested assumptions aout the role of psychotherapy treatment manuals in evidence-based mental health practice. Clin Psychol Sci Pract. 2002;9:421–4.
36. Shadish WR, Matt GE, Navarro AM, Siegle G, Crits-Christoph P, Hazelrigg MD, et al. Evidence that therapy works in clinically representative conditions. J Consult Clin Psychol. 1997;65:355–65. [PubMed] 37. Weisz JR, Jensen-Doss A, Hawley KM. Evidence-based youth psychotherapies versus usual clinical care. Am Psychol. 2006;61:671–89. [PubMed]
38. Addis ME. Methods for disseminating research products and increasing evidence-based practice: promises, obstacles, and future directions. Clin Psychol Sci Pract. 2002;9:367–78.
39. Hanson GR, Leshner AI, Tai B. Putting drug abuse research to work in real-life settings. J Subst Abuse Treat. 2002;23:69–70. [PubMed] 40. Carroll KM, Rounsaville BJ. Bridging the gap between research and practice in substance abuse treatment: a hybrid model linking efficacy and effectiveness research. Psychiatr Serv. 2003;54:333–9. [PMC free article] [PubMed] 41. Peirce JM, Petry NM, Stitzer ML, Blaine JD, Kellog S, Satterfield F, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry. 2006;63:201–8. [PubMed] 42. Petry NM, Peirce JM, Stitzer ML, Blaine JD, Roll JM, Cohen A, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse Clinical Trials Network study. Arch Gen Psychiatry. 2005;62:1148–56. [PubMed] 43. Carroll KM, Ball SA, Nich C, Martino S, Frankforter T, Farentinos C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006;81:301–12. [PMC free article] [PubMed]
44. Ball SA, Martino S, Nich C, Frankforter TL, Van Horn DH, Crits-Christoph P, et al. Site matters: motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol. in press.
45. Ling W, Amass L, Shoptaw S, Annon JJ, Hillhouse M, Babcock D, et al. 2005 A multicenter randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction. 2006;100:1090–100. [PMC free article] [PubMed] 46. Carroll KM, Farentinos C, Ball SA, Crits-Christoph P, Libby B, Morgenstern J, et al. MET meets the real world: design issues and clinical strategies in the Clinical Trials Network. J Subst Abuse Treat. 2002;23:73–80. [PMC free article] [PubMed] 47. Collins LM, Murphy SA, Bierman KL. A conceptual framework for adaptive preventive interventions. Prev Sci. 2004;5:185–96. [PMC free article] [PubMed] 48. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, et al. Bupropion-SR, sertra-line, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354:1231–42. [PubMed] 49. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25:119–42. [PubMed] 50. Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243–52. [PubMed] 51. Murphy SA, Lynch KG, Oslin D, McKay JR, Tenhave T. Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend. 2007;88(Suppl 2):S24–S39. [PMC free article] [PubMed] 52. O’Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, et al. Initial and maintenance naltrex-one treatment for alcohol dependence using primary care vs. specialty care: a nested sequence of three randomized trials. Arch Intern Med. 2003;163:1695–704. [PubMed]
53. Onken LS, Blaine JD, Battjes R. Behavioral therapy research: a conceptualization of a process. In: Hennegler SW, Amentos R, editors. Innovative approaches for difficult to treat populations. Washington, DC: American Psychiatric Press; 1997. pp. 477–85.
54. Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from Stage I. Clin Psychol Sci Pract. 2001;8:133–42.
55. Hohmann AA, Shear MK. Community-based intervention research: coping with the ‘noise’ of real life in study design. Am J Psychiatry. 2002;159:202–7. [PubMed] 56. Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97:265–77. [PubMed] 57. MTP Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72:455–66. [PubMed] 58. Carroll KM, Easton CJ, Nich C, Hunkele KA, Neavins TM, Sinha R, et al. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol. 2006;74:955–66. [PMC free article] [PubMed] 59. Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003–17. [PubMed]
60. Olmstead T, Sindelar JL, Easton CJ, Carroll KM. The cost-effectiveness of four treatments for marijuana dependence. Addiction. in press.
61. Weissman MM, Verdeli H, Gameroff MJ, Bledsoe SE, Betts K, Mufson L, et al. National survey of psychotherapy training in psychiatry, psychology, and social work. Arch Gen Psychiatry. 2006;63:925–34. [PubMed]
62. Crits-Christoph P, Frank E, Chambless DL, Brody C, Karp JF. Training in empirically validated therapies: what are clinical psychology students learning? Profess Psychol Res Pract. 1995;26:514–22.
63. Davis DA, Thomson MA, Oxman AD, Haynes RB. Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. JAMA. 1992;268:1111–17. [PubMed]
64. Gotham HJ. Diffusion of mental health and substance abuse treatments: development, dissemination, and implementation. Clin Psychol Sci Pract. 2004;11:160–76.
65. VandeCreek L, Knapp S, Brace K. Mandatory continuing education for licensed psychologists: its rationale and current implications. Profess Psychol Res Pract. 1990;21:135–40.
66. Barlow DH, Levitt JT, Bufka LF. The dissemination of empirically supported treatments: a view to the future. Behav Res Ther. 1999;37:S147–62. [PubMed] 67. Miller WR, Yahne CE, Moyers TB, Martinez J, Pirritano M. A randomized trial of methods to help clinicians learn motivation interviewing. J Consult Clin Psychol. 2004;72:1050–62. [PubMed]
68. Rubel EC, Sobell LC, Miller WR. Do continuing workshops improve participants skills? Effects of a motivational interviewing workshop on substance-abuse counselors’ skills and knowledge. Behav Ther. 2000;23:73–7.
69. Sholomskas D, Syracuse G, Ball SA, Nuro KF, Rounsaville BJ, Carroll KM. We don’t train in vain: a dissemination trial of three strategies for training clinicians in cognitive behavioral therapy. J Consult Clin Psychol. 2005;73 :106–15. [PMC free article] [PubMed] 70. Crits-Christoph P, Siqueland L, Chittams J, Barber JP, Beck AT, Frank A, et al. Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence. J Consult Clin Psychol. 1998;66:484–92. [PubMed] 71. Weissman MM, Rounsaville BJ, Chevron E. Training psychotherapists to participate in psychotherapy outcome studies. Am J Psychiatry. 1982;139:1442–6. [PubMed] 72. Carroll KM, Connors GJ, Cooney NL, DiClemente CC, Donovan DM, Longabaugh RL, et al. Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol. 1998;66:290–303. [PubMed] 73. Vakoch DA, Strupp HH. The evolution of psychotherapy training: reflections on manual-based learning and future activities. J Clin Psychol. 2000;56:309–18. [PubMed]
74. Miller WR, Moyers TB, Arciniega L, Ernst D, Force-himes A. Training, supervision and quality monitoring of the COMBINE Study behavioral interventions. J Stud Alcohol. 2005;15(Suppl):188–95. discussion 168–9.
75. Tober G, Godfrey C, Parrott S, Copello A, Farrin A, Hodgson R, et al. Setting standards for training and competence: the UK alcohol treatment trial. Alcohol Alcohol. 2005;40:413–8. [PubMed] 76. Carroll KM, Kadden R, Donovan D, Zweben A, Roun-saville BJ. Implementing treatment and protecting the validity of the independent variable in treatment matching studies. J Stud Alcohol. 1994;(Suppl 12):149–55. [PubMed] 77. Baer JS, Ball SA, Campbell BK, Miele GM, Schoener EP, Tracy K. Training and fidelity monitoring of behavioral interventions in multi-site addictions research. Drug Alcohol Depend. 2007;87:107–18. [PMC free article] [PubMed] 78. Andrzejewski ME, Kirby KC, Morral AR, Iguchi MY. Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors’ behavior. Drug Alcohol Depend. 2001;63:179–86. [PubMed] 79. Martin GW, Herie MA, Turner BJ, Cunningham JA. A social marketing model for disseminating research-based treatments to addictions treatment providers. Addiction. 1998;93:1703–15. [PubMed] 80. Henggeler SW, Schoenwald SK, Liao JG, Letourneau EJ, Edwards DL. Transporting efficacious treatments to field settings: the link between supervisory practices and therapist fidelity in MST programs. J Clin Child Adolesc Psychol. 2002;31:155–67. [PubMed] 81. Carroll KM, Nich C, Sifry R, Nuro KF, Frankforter T, Ball SA, et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 2000;57:225–38. [PubMed] 82. Waltz J, Addis ME, Koerner K, Jacobson NS. Testing the integrity of a psychotherapy protocol: assessment of adherence and competence. J Consult Clin Psychol. 1993;61 :620–30. [PubMed] 83. Calhoun KS, Moras K, Pilkonis PA, Rehm LP. Empirically supported treatments: implications for training. J Consult Clin Psychol. 1998;66:151–62. [PubMed] 84. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat. 2003;25:117–21. [PubMed]
85. McLellan AT. What we need is a system: creating a responsive and effective substance abuse treatment system. In: Miller WR, Carroll KM, editors. Rethinking substance abuse: what the science shows and what we should do about it. New York: Guilford Press; 2006. pp. 275–92.
86. Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 2007;87:175–82. [PMC free article] [PubMed]
87. Chiles JA, Lambert ME, Hatch AL. The impact of psychological interventions on medical cost offset: a meta-analytic review. Clin Psychol Sci Pract. 1999;6:204–20.
88. Yates BT. Toward the incorporation of costs, cost-effectiveness analysis, and cost–benefit analysis into clinical research. J Consult Clin Psychol. 1994;62:729–36. [PubMed] 89. Addis ME, Krasnow AD. A national survey of practicing psychologists’ attitudes toward psychotherapy treatment manuals. J Consult Clin Psychol. 2000;68:430–41. [PubMed]
90. Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychother Theory Res Pract. 1982;19:276–88.
91. Beutler LE, Moleiro C, Talebi H. How practitioners can systematically use empirical evidence in treatment selection. J Clin Psychol. 2002;58:1199–212. [PubMed] 92. Kazdin AE, Nock MK. Delineating mechanisms of change in child and adolescent therapy: methodological issues and research recommendations. J Child Psychol Psychiatry. 2003;44:1116–29. [PubMed] 93. O’Donohue W, Yeater EA. Individuating psychotherapies. Behav Modif. 2003;27:313–21. [PubMed]
94. Haaga DAF. Being systematic, and maybe even scientific, about planning psychotherapy research. Clin Psychol Sci Pract. 2004;11:387–0.
95. O’Donohue W, Buchanan JA, Fisher JE. Characteristics of empirically supported treatments. J Psychother Pract Res. 2000;9:69–74. [PMC free article] [PubMed]
96. Beutler LE, Clarkin JF, Bongar BM. Guidelines for the Systematic Treatment of Depressed Patients. New York: Oxford University Press; 2000.
97. Beutler LE, Harwood HJ. Prescriptive Psychotherapy: a Practical Guide to Systematic Treatment Selections. New York: Oxford University Press; 2000.
98. Ball SA, Bachrach K, DeCarlo J, Farentinos C, Keen M, McSherry T, et al. Characteristics of community clinicians trained to provide manual-guided therapy for substance abusers. J Subst Abuse Treat. 2002;23:309–18. [PubMed] 99. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289:1969–75. [PubMed]
100. Wiltsey Stirman S, Crits-Christoph P, DeRubeis RJ. Achieving successful dissemination of empirically supported therapies: a synthesis of dissemination theory. Clin Psychol Sci Pract. 2004;11:343–59.
101. Petry NM. A comprehensive guide to the application of contigency management procedures in clinical settings. Drug Alcohol Depend. 2000;58:9–25. [PubMed] 102. Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ. Schedule of voucher delivery influences initiation of cocaine abstinence. J Consult Clin Psychol. 1998;66:761–7. [PubMed] 103. DeRubeis RJ, Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental disorders. J Consult Clin Psychol. 1998;66:37–52. [PubMed] 104. Weissman MM, Markowitz JC. Interpersonal psychotherapy. current status. Arch Gen Psychiatry. 1994;51:599–606. [PubMed] 105. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55:305–12. [PMC free article] [PubMed] 106. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843–61. [PubMed] 107. Henggeler SW, Melton GB, Brondino MJ, Scherer DG, Hanley JH. Multisystemic therapy with violent and chronic juvenile offenders and their families: the role of treatment fidelity. J Consult Clin Psychol. 1997;65:821–33. [PubMed] 108. Foley SH, O’Malley SS, Rounsaville BJ. The relationship between patient difficulty and therapist performance in interpersonal psychotherapy. J Affect Disord. 1987;12:207–17. [PubMed] 109. Barber JG, Crits-Christoph P, Luborsky L. Effects of therapist adherence and competence on patient outcome in brief dynamic therapy. J Consult Clin Psychol. 1996;64:619–22. [PubMed] 110. Henry WP, Strupp HH, Butler SF, Schacht TE, Binder JL. Effects of training in time-limited dynamic psychotherapy: changes in therapist behavior. J Consult Clin Psychol. 1993;61:434–40. [PubMed] 111. Castonguay LG, Goldfried MR, Wiser S, Raue PJ, Hayes AM. Predicting the effect of cognitive therapy for depression: a study of unique and common factors. J Consult Clin Psychol. 1996;64:497–504. [PubMed] 112. Sholomskas DE, Carroll KM. One small step for manuals: computer-assisted training in twelve-step facilitation. J Stud Alcohol. 2006;67:939–45. [PMC free article] [PubMed] 113. Issenberg SB, McGaghie WC, Hart IR, Mayer JW, Felner JM, Petrusa ER, et al. Simulation technology for health care professional skills training and assessment. JAMA. 1999;282:861–6. [PubMed] 114. Todd KH, Braslow A, Brennan RT, Lowery DW, Cox RJ, Lipscomb LE, et al. Randomized, controlled trial of video self-instruction versus traditional CPR training. Ann Emerg Med. 1998;31:364–9. [PubMed] 115. Huang MP, Alessi NE. The internet and the future of psychiatry. Am J Psychiatry. 1996;153:861–9. [PubMed] 116. Piemme TE. Computer-assisted learning and evaluation in medicine. JAMA. 1988;260:367–72. [PubMed]
117. Jones I, Cookson J. Computer-assisted learning design for reflective practice supporting multiple learning styles for education and training in pre-hospital emergency care. Int J Train Dev. 2001;5:74–80.
118. Budman SH. Computer-mediated addiction services: tomorrow won’t look like today. Behav Healthcare Tomorrow. 2002;11:14–21. [PubMed] 119. Davis DD, Thompson O’Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education. JAMA. 1999;282:867–74. [PubMed] 120. Williams CD, Aubin S, Harkin P, Cottrell D. A randomized, controlled, single-blind trial of teaching provided by a computer-based multimedia package versus lecture. Med Educ. 2001;35:847–54. [PubMed] 121. Carise D, McLellan AT, Gifford LS, Kleber HD. 1999 Developing a national addiction treatment information system: an introduction to the Drug Evaluation Network System. J Subst Abuse Treat. 2002;17:67–77. [PubMed]
122. McLellan AT, Belding MA, McKay JR, Zanis D, Alterman AI. Can the outcomes research literature inform the search for quality indicators in substance abuse treatment? In: Edmunds M, Frank RG, Hogan M, McCarty D, Robinson-Beale R, Weisner C, editors. Managing managed care: quality improvement in behavioral health. Washington, DC: National Academy Press; 1996.
123. Keane DR, Norman GR, Vickers J. The inadequacy of recent research on computer-assisted instruction. Acad Med. 1991;66:44–8. [PubMed] 124. Clark RE. Dangers in evaluation of instructional media. Acad Med. 1992;12:819–20. [PubMed] 125. Vogel M, Wood DF. Love it or hate it? Medical students’ attitudes to computer-assisted learning. Med Educ. 2002;36 :214–15. [PubMed] 126. Cook DA. Learning and cognitive styles in web-based learning: theory, evidence, and application. Acad Med. 2005;80:266–78. [PubMed]
127. Lane JM, Addis ME. Pros and cons of educational technology as methods for disseminating evidence-based treatments. Clin Psychol Sci Pract. 2004;11:336–8.
128. Crits-Christoph P, Baranackie K, Kurcias J, Beck AT, Carroll KM, Perry K, et al. Meta-analysis of therapist effects in psychotherapy outcome studies. Psychother Res. 1991;1:81–91.
129. Carroll KM. Constrained, confounded, and confused: why we know so little about therapist effects. Addiction. 2001;96 :203–6. [PubMed]
130. Project MATCH Research Group. Therapist effects in three treatments for alcohol problems. Psychother Res. 1998;8:455–74.
131. Budman SH. Behavioral health care dot-com and beyond: computer-mediated communications in mental health and substance abuse treatment. Am Psychol. 2000;55:1290–300. [PubMed]
132. Marks I, Shaw S, Parkin R. Computer-aided treatments of mental health problems. Clin Psychol Sci Pract. 1998;5:151–70.
133. Norquist G, Regier DA. The epidemiology of psychiatric disorders and the de facto mental health care system. Annu Rev Med. 1996;47:473–9. [PubMed] 134. Kirkby KC. Computer-assisted treatment of phobias. Psychiatr Serv. 1996;47:139–40. [PubMed] 135. Baer L, Greist JH. An interactive computer-administered self-assessment and self-help program for behavior therapy. J Clin Psychiatry. 1997;58:23–8. [PubMed] 136. Newman MG, Kenardy J, Herman S, Taylor CB. Comparison of palmtop-computer assisted brief cognitive-behavioral treatment to cognitive-behavioral treatment for panic disorder. J Consult Clin Psychol. 1997;65:178–83. [PubMed] 137. Wright JH, Wright AS, Albano AM, Basco MR, Goldsmith LJ, Raffield T, et al. Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry. 2005;162:1158–64. [PubMed] 138. Selmi PM, Klein MH, Greist JH, Sorrell SP, Erdman HP. Computer-administered CBT for depression. Am J Psychiatry. 1990;147:51–6. [PubMed] 139. Slate SE, Meyer TL, Burns WJ, Montgomery DD. Computerized cognitive training for severely emotionally disturbed children with ADHD. Behav Modif. 1998;22:415–20. [PubMed] 140. Shiffman S, Paty JA, Rohay JM, DiMarino ME, Gitchell JG. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy. Drug Alcohol Depend. 2001;64:35–46. [PubMed]
141. Carroll KM. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, MD: NIDA;
142. Paul GL. 1967 Strategy of outcome research in psychotherapy. J Clin Psychol. 1998;31:109–18. [PubMed] 143. Paul GL, Licht MH. Resurrection of the uniformity assumption myth and the fallacy of statistical absolutes in psychotherapy research. J Consult Clin Psychol. 1978;46:1531–4. [PubMed]